The paper provides an insight into MS and particulary its tretment in pregnancy based on previous experience and results of strudies ENTIS and CZTIS. the rusults of epidemiologicyl studies suggests that for normal fetal development it is essential to keep the disease in remission, even at the expense of adequate treatment. When selecting medications, it is important to favor those with a wrll-known and low risk of embryotoxicity.
The pregnancy has to be monitored closely by ultrasound with respect to structural defects and intrauterine growth retardation.